Cassava Sciences, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -3.86%121.720.0%$408.36m
ICLRICON plc 3.72%217.292.8%$327.40m
VRXValeant Pharmaceuticals International, Inc. 0.40%28.7114.1%$168.93m
HZNPHorizon Therapeutics Plc 1.18%101.255.5%$131.73m
JAZZJazz Pharmaceuticals Plc -0.10%173.642.2%$88.25m
CTLTCatalent, Inc. 0.83%116.152.1%$77.88m
PRGOPerrigo Co. Plc 1.27%46.406.9%$51.48m
UTHRUnited Therapeutics Corp. -0.64%184.6114.0%$49.04m
BHCBausch Health Cos., Inc. 0.40%28.710.0%$43.91m
ENDPEndo International Plc 0.61%4.928.6%$43.62m
ARGXargenx SE 0.10%316.900.0%$40.76m
SAGESAGE Therapeutics, Inc. -2.71%44.537.6%$34.08m
IRWDIronwood Pharmaceuticals, Inc. 0.81%13.109.6%$28.51m
ZGNXZogenix, Inc. 4.12%17.957.5%$23.84m
AXSMAxsome Therapeutics, Inc. -3.58%53.881.9%$19.99m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.